NVLPF (Nova Leap Health) Forward PE Ratio: 32.20 (As of Jul. 05, 2026)


NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.25
GF Value $0.18
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nova Leap Health Forward PE Ratio?

Nova Leap Health NVLPF 50 Forward PE Ratio is 32.20 as of Jul. 05, 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 312 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 64.74% on this metric.

Nova Leap Health's Forward PE Ratio for today is 32.20.

Nova Leap Health's PE Ratio without NRI for today is 33.08.

Nova Leap Health's PE Ratio (TTM) for today is 107.50.


Nova Leap Health  (OTCPK:NVLPF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Nova Leap Health Forward PE Ratio Related Terms


Nova Leap Health Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health Forward PE Ratio Chart

Nova Leap Health Annual Data
Trend 2021-12 2022-12
Forward PE Ratio
23.20 6.77

Nova Leap Health Quarterly Data
2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2024-03 2024-06
Forward PE Ratio 104.17 31.35 27.25 23.20 23.31 14.99 7.00 6.77 6.39 19.08 21.98

NVLPF vs HCA, THC, DVA: Forward PE Ratio Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health Forward PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's Forward PE Ratio falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 32.20 mean?
Nova Leap Health (NVLPF) has a Forward PE Ratio of 32.20 as of Jul. 05, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #202 out of 312 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is Nova Leap Health's Forward PE Ratio too high?
Nova Leap Health's current Forward PE Ratio is 32.20. The Healthcare Providers & Services industry median Forward PE Ratio is 18.40. Nova Leap Health's value of 32.20 is 75% above this industry median. Based on the distribution chart, Nova Leap Health ranks #202 out of 312 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #202 out of 312 companies for Forward PE Ratio. This places Nova Leap Health in the lower half of its industry. The industry median Forward PE Ratio is 18.40. Nova Leap Health's value of 32.20 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.40, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Forward PE Ratio of 32.20 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Forward PE Ratio is 32.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.18, compared to a current price of $0.25 — trading 36.9% above its estimated fair value. The current Forward PE Ratio is 32.20 and 75% above the Healthcare Providers & Services industry median of 18.40. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Forward PE Ratio is 32.20 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.25 is trading 36.9% above its estimated GF Value™ of $0.18. GuruFocus considers Nova Leap Health to be Fairly Valued.

Key valuation signals for NVLPF:

  • Forward PE Ratio: 32.20
  • GF Value™: $0.18 vs. price of $0.25 (36.9% above fair value)
  • GF Score™: 50/100 with 4 warning signs
  • Industry Position: 75% above the Healthcare Providers & Services median (#202 of 312)

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$0.18
GF Value